비교리스트

 카트 문의
시장보고서
상품코드
1679419

대규모 및 소규모 바이오프로세스 시장 규모, 점유율, 동향 분석 보고서 : 워크플로우별, 제품 유형별, 모드별, 지역별, 부문별 예측(2025-2030년)

Large And Small-scale Bioprocessing Market Size, Share & Trends Analysis Report By Workflow (Downstream, Upstream), By Product, By Use Type, By Mode (In-house, Outsourced), By Region, And Segment Forecasts, 2025 - 2030
발행일: | 리서치사: Grand View Research | 페이지 정보: 영문 110 Pages | 배송안내 : 2-10일 (영업일 기준)

    
    
    




※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

시장 규모 및 동향

전 세계 대규모 및 소규모 바이오프로세스 시장 규모는 2024년 805억 달러로 평가되며, 2025-2030년 사이 13.8%의 CAGR로 성장할 것으로 예상됩니다.

바이오프로세스 공학은 바이오의약품 개발을 위해 효과적으로 탐구되고 있으며, 바이오 제조업체와 위탁생산기관(CMO)에 유리한 성장 경로를 제공하고 있습니다. 따라서 다양한 바이오프로세스 공학 솔루션의 시장 도입을 강화하기 위한 중점적인 노력이 기대됩니다.

대규모 바이오프로세스는 바이오의약품 및 기타 생물학적 제제를 대규모로 생산하는 것으로, 일반적으로 대형 바이오 반응기와 대규모 시설을 사용합니다. 반면, 소규모 바이오프로세스는 생산 조건을 보다 정밀하게 제어하기 위해 마이크로 바이오 반응기나 연질 시스템을 이용하는 경우가 많으며, 더 작은 배치에 중점을 둡니다. 두 가지 규모 모두 대량 생산되는 백신에서 맞춤형 의약품에 이르기까지 다양한 시장 수요를 충족시키는 데 매우 중요합니다. 바이오의약품에 대한 수요는 암이나 당뇨병과 같은 만성질환에 대한 표적 치료제를 제공한다는 점에서 이 시장의 큰 촉진제가 되고 있습니다. 이러한 수요 증가는 첨단 배양 시스템 및 여과 장비와 같은 기술에 대한 투자를 촉진하여 바이오프로세싱 시스템이 규제 준수를 유지하면서 효율적으로 확장할 수 있도록 합니다.

바이오프로세스 기술이 발전함에 따라 제조업체들은 효율성 향상, 비용 절감, 제품 품질 향상을 위해 혁신적인 솔루션을 채택하고 있습니다. 일회용 기술 및 자동화를 포함한 기술 발전은 시장 성장을 촉진하는 데 매우 중요한 역할을 하고 있습니다. 이러한 기술 혁신은 보다 효율적이고 비용 효율적인 생산 방식을 가능하게 하고, 공정 관리를 강화하며, 오염 위험을 최소화합니다. 또한, 맞춤형 의료로의 전환은 품질 저하 없이 소량 배치 크기에 적응할 수 있는 확장 가능한 바이오프로세싱 솔루션을 요구하고 있습니다. 이러한 맞춤화 추세는 바이오프로세스 시장을 강력한 성장으로 이끌고 있습니다.

생명공학 연구에 대한 투자 증가도 시장을 크게 견인하고 있습니다. 정부와 민간 부문은 생명공학 혁신을 위해 막대한 자금을 투입하고 있으며, 학계, 연구기관, 산업계의 협력을 촉진하고 있습니다. 예를 들어, 영국 바이오산업협회(BIA)에 따르면, 영국의 바이오테크놀러지 보조금은 2025/2026년에 증가할 것으로 예상됩니다. 생명공학 및 의료 부문은 연구개발비로 약 1억 6,000만 달러 이상, 설비 투자로 5,000만 달러 이상을 지원받습니다. 혁신 자금은 5배 증가한 10억 달러 이상에 달할 것이며, 자금이 부족한 지역과 의료 등 디지털화가 진행되고 있는 부문에 집중될 것으로 보입니다.

영국 정부는 타겟팅된 인센티브를 통해 혁신과 경제 성장을 강화할 계획입니다. 이러한 자금의 급격한 증가는 첨단 바이오프로세스 기술과 시설의 개발을 지원하여 향후 몇 년 동안 상당한 성장을 촉진할 것입니다. 바이오프로세스 기반 강화를 위해 더 많은 자원이 할당됨에 따라 기술 발전, 바이오의약품 수요 증가, R&D에 대한 전략적 투자의 상호 작용에 따라 시장은 더욱 확대될 것으로 예상됩니다.

목차

제1장 조사 방법과 범위

제2장 주요 요약

제3장 대규모 및 소규모 바이오프로세스 시장 변수, 동향, 범위

  • 시장 계통 전망
  • 시장 역학
    • 시장 성장 촉진요인 분석
    • 시장 성장 억제요인 분석
  • 비즈니스 환경 분석
    • 산업 분석 - Porter's Five Forces 분석
    • PESTLE 분석

제4장 대규모 및 소규모 바이오프로세스 시장 : 규모 비즈니스 분석

  • 규모 시장 점유율, 2024년과 2030년
  • 규모 부문 대시보드
  • 시장 규모와 예측과 동향 분석, 규모별, 2018-2030년
  • 산업 규모(5만 리터 이상)
  • 소규모(5만 리터 이하)

제5장 대규모 및 소규모 바이오프로세스 시장 : 워크플로우 비즈니스 분석

  • 워크플로우 시장 점유율, 2024년과 2030년
  • 워크플로우 부문 대시보드
  • 시장 규모와 예측과 동향 분석, 워크플로우별, 2018-2030년
  • 다운스트림 처리
  • 발효
  • 업스트림 처리

제6장 대규모 및 소규모 바이오프로세스 시장 : 제품 비즈니스 분석

  • 제품 시장 점유율, 2024년과 2030년
  • 제품 부문 대시보드
  • 시장 규모와 예측과 동향 분석, 제품별, 2018-2030년
  • 바이오리액터/발효조
  • 세포배양 제품
  • 여과 어셈블리
  • 바이오리액터 액세서리
  • 백과 용기
  • 기타

제7장 대규모 및 소규모 바이오프로세스 시장 : 용도 비즈니스 분석

  • 용도 시장 점유율, 2024년과 2030년
  • 용도 부문 대시보드
  • 시장 규모와 예측과 동향 분석, 용도별, 2018-2030년
  • 바이오의약품
  • 특수 산업용 화학제품
  • 환경 보조

제8장 대규모 및 소규모 바이오프로세스 시장 : 제품 유형 비즈니스 분석

  • 제품 유형 시장 점유율, 2024년과 2030년
  • 제품 유형 부문 대시보드
  • 시장 규모와 예측과 동향 분석, 제품 유형별, 2018-2030년
  • 다용도
  • 일회용

제9장 대규모 및 소규모 바이오프로세스 시장 : 모드 비즈니스 분석

  • 모드 시장 점유율, 2024년과 2030년
  • 모드 부문 대시보드
  • 시장 규모와 예측과 동향 분석, 모드별, 2018-2030년
  • 바이오의약품
  • 특수 산업용 화학제품
  • 사내
  • 아웃소싱

제10장 대규모 및 소규모 바이오프로세스 시장 : 지역별, 추정·동향 분석

  • 지역별 시장 점유율 분석, 2024년과 2030년
  • 지역별 시장 대시보드
  • 시장 규모, 예측 동향 분석, 2018-2030년
  • 북미
    • 국가별, 2018-2030년
    • 미국
    • 캐나다
    • 멕시코
  • 유럽
    • 국가별, 2018-2030년
    • 독일
    • 영국
    • 프랑스
    • 이탈리아
    • 스페인
    • 덴마크
    • 스웨덴
    • 노르웨이
  • 아시아태평양
    • 국가별, 2018-2030년
    • 일본
    • 중국
    • 인도
    • 호주
    • 태국
    • 한국
  • 라틴아메리카
    • 국가별, 2018-2030년
    • 브라질
    • 아르헨티나
  • 중동 및 아프리카
    • 국가별, 2018-2030년
    • 남아프리카공화국
    • 사우디아라비아
    • 아랍에미리트
    • 쿠웨이트

제11장 경쟁 구도

  • 참여자 개요
  • 기업의 시장 포지션 분석
  • 기업 분류
  • 전략 매핑
  • 기업 개요/상장 기업
    • Merck KGaA
    • Thermo Fisher Scientific, Inc.
    • GE healthcare
    • Corning, Inc.
    • Sartorius AG
    • CESCO BIOENGINEERING CO., LTD
    • Bio-Process Group
    • Bioprocess Control AB
    • Eppendorf AG
    • Applikon BIoTechnology
    • Lonza
    • PBS BIoTech, Inc
    • Finesse
    • Meissner Filtration Products, Inc.
    • CellGenix GmbH
    • Boehringer Ingelheim
    • Samsung BioLogics
    • Patheon
    • CMC Biologics
    • Binex Co., Ltd
    • Rentschler BIoTechnology GmbH
    • TOYOBA CO., LTD.
    • Inno Biologics Sdn Bhd
    • F. Hoffmann-La Roche Ltd
ksm 25.04.16

Market Size & Trends:

The global large and small-scale bioprocessing market size was valued at USD 80.5 billion in 2024 and is expected to grow at a CAGR of 13.8% from 2025 to 2030. Bioprocess engineering has been effectively explored for the development of biopharmaceuticals, and it has provided bio manufacturers and contract manufacturing organizations (CMOs) with lucrative avenues of growth. This, in turn, is expected to attract focused efforts to bolster the market adoption of various bioprocess engineering solutions.

Large Scale Bioprocessing involves the production of biopharmaceuticals and other biological products on a massive scale, typically using large bioreactors and extensive facilities. Whereas, small scale bioprocessing focuses on smaller batches, often utilizing micro-bioreactors and flexible systems for more precise control over production conditions. Both scales are crucial for meeting diverse market demands, from mass-produced vaccines to personalized medicines. The demand for biopharmaceuticals is a significant driver of this market, as these products offer targeted therapies for chronic diseases such as cancer and diabetes. This increasing demand fuels investments in technologies such as advanced incubation systems and filtration devices, ensuring that bioprocessing systems can scale efficiently while maintaining regulatory compliance.

As bioprocessing technologies evolve, manufacturers are adopting innovative solutions to enhance efficiency, reduce costs, and improve product quality. Technological advancements, including single-use technologies and automation, play a pivotal role in driving market growth. These innovations enable more efficient and cost-effective production methods, enhance process control, and minimize contamination risks. Furthermore, the shift towards personalized medicine necessitates scalable bioprocessing solutions that can adapt to smaller batch sizes without compromising quality. This customization trend positions the bioprocessing market for robust growth.

Rising investments in biotechnology research also significantly boost the market. Governments and private sectors are directing substantial funding towards biotechnological innovations, promoting collaborations between academic institutions, research organizations, and industry players. For instance, according to the UK Bio industy Association (BIA), UK biotechnology grant funding is expected to grow in 2025/2026. The Biotech and Medical sector received approximately over USD 160 million for R&D and over USD 50 million for capital investments in equipment. Innovation funding experienced a five-fold is projected to reach over USD 1 billion, focusing on under-funded regions and sectors undergoing digitalization such as healthcare.

The UK government plans to enhance innovation and economic growth via targeted incentives. This surge in funding supports the development of advanced bioprocessing techniques and facilities, driving substantial growth in the coming years. As more resources are allocated towards enhancing bioprocessing infrastructures, the market is poised to expand further, driven by the interplay of technological advancements, increasing demand for biopharmaceuticals, and strategic investments in research and development.

Global Large And Small-scale Bioprocessing Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global large and small-scale bioprocessing market report based on scale, workflow, product, application, use type, mode, and region:

  • Scale Outlook (Revenue, USD Million, 2018 - 2030)
  • Industrial Scale (Over 50,000 Litre)
  • Small Scale (Less Than 50,000 Litre)
  • Workflow Outlook (Revenue, USD Million, 2018 - 2030)
  • Downstream Processing
  • Fermentation
  • Upstream Processing
  • Product Outlook (Revenue, USD Million, 2018 - 2030)
  • Bioreactors/Fermenters
  • Cell Culture Products
  • Filtration Assemblies
  • Bioreactors Accessories
  • Bags & Containers
  • Others
  • Application Outlook (Revenue, USD Million, 2018 - 2030)
  • Biopharmaceuticals
  • Speciality Industrial Chemicals
  • Environmental Aids
  • Use Type Outlook (Revenue, USD Million, 2018 - 2030)
  • Multi-Use
  • Single-Use
  • Mode Outlook (Revenue, USD Million, 2018 - 2030)
  • In-house
  • Outsourced
  • Regional Outlook (Revenue, USD Million, 2018 - 2030)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • Thailand
    • South Korea
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Scale
    • 1.2.2. Workflow
    • 1.2.3. Product
    • 1.2.4. Application
    • 1.2.5. Use Type
    • 1.2.6. Mode
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Large and Small-Scale Bioprocessing Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Business Environment Analysis
    • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
      • 3.3.1.1. Supplier Power
      • 3.3.1.2. Buyer Power
      • 3.3.1.3. Substitution Threat
      • 3.3.1.4. Threat of New Entrants
      • 3.3.1.5. Competitive Rivalry
    • 3.3.2. PESTLE Analysis

Chapter 4. Large and Small-Scale Bioprocessing Market: Scale Business Analysis

  • 4.1. Scale Market Share, 2024 & 2030
  • 4.2. Scale Segment Dashboard
  • 4.3. Market Size & Forecasts and Trend Analysis, by Scale, 2018 to 2030 (USD Million)
  • 4.4. Industrial Scale (Over 50,000 Litre)
    • 4.4.1. Industrial Scale (Over 50,000 Litre) Market, 2018 - 2030 (USD Million)
  • 4.5. Small Scale (Less Than 50,000 Litre)
    • 4.5.1. Small Scale (Less Than 50,000 Litre) Market, 2018 - 2030 (USD Million)

Chapter 5. Large and Small-Scale Bioprocessing Market: Workflow Business Analysis

  • 5.1. Workflow Market Share, 2024 & 2030
  • 5.2. Workflow Segment Dashboard
  • 5.3. Market Size & Forecasts and Trend Analysis, by Workflow, 2018 to 2030 (USD Million)
  • 5.4. Downstream Processing
    • 5.4.1. Downstream Processing Market, 2018 - 2030 (USD Million)
  • 5.5. Fermentation
    • 5.5.1. Fermentation Market, 2018 - 2030 (USD Million)
  • 5.6. Upstream Processing
    • 5.6.1. Upstream Processing Market, 2018 - 2030 (USD Million)

Chapter 6. Large and Small-Scale Bioprocessing Market: Product Business Analysis

  • 6.1. Product Market Share, 2024 & 2030
  • 6.2. Product Segment Dashboard
  • 6.3. Market Size & Forecasts and Trend Analysis, by Product, 2018 to 2030 (USD Million)
  • 6.4. Bioreactors/Fermenters
    • 6.4.1. Bioreactors/Fermenters Market, 2018 - 2030 (USD Million)
  • 6.5. Cell Culture Products
    • 6.5.1. Cell Culture Products Market, 2018 - 2030 (USD Million)
  • 6.6. Filtration Assemblies
    • 6.6.1. Filtration Assemblies Market, 2018 - 2030 (USD Million)
  • 6.7. Bioreactors Accessories
    • 6.7.1. Bioreactors Accessories Market, 2018 - 2030 (USD Million)
  • 6.8. Bags & Containers
    • 6.8.1. Bags & Containers Market, 2018 - 2030 (USD Million)
  • 6.9. Other
    • 6.9.1. Other Market, 2018 - 2030 (USD Million)

Chapter 7. Large and Small-Scale Bioprocessing Market: Application Business Analysis

  • 7.1. Application Market Share, 2024 & 2030
  • 7.2. Application Segment Dashboard
  • 7.3. Market Size & Forecasts and Trend Analysis, by Application, 2018 to 2030 (USD Million)
  • 7.4. Biopharmaceuticals
    • 7.4.1. Biopharmaceuticals Market, 2018 - 2030 (USD Million)
  • 7.5. Speciality Industrial Chemicals
    • 7.5.1. Speciality Industrial Chemicals Market, 2018 - 2030 (USD Million)
  • 7.6. Environmental Aids
    • 7.6.1. Environmental Aids Market, 2018 - 2030 (USD Million)

Chapter 8. Large and Small-Scale Bioprocessing Market: Use Type Business Analysis

  • 8.1. Use Type Market Share, 2024 & 2030
  • 8.2. Use Type Segment Dashboard
  • 8.3. Market Size & Forecasts and Trend Analysis, by Use Type, 2018 to 2030 (USD Million)
  • 8.4. Multi-Use
    • 8.4.1. Multi-Use Market, 2018 - 2030 (USD Million)
  • 8.5. Single-Use
    • 8.5.1. Single-Use Market, 2018 - 2030 (USD Million)

Chapter 9. Large and Small-Scale Bioprocessing Market: Mode Business Analysis

  • 9.1. Mode Market Share, 2024 & 2030
  • 9.2. Mode Segment Dashboard
  • 9.3. Market Size & Forecasts and Trend Analysis, by Mode, 2018 to 2030 (USD Million)
  • 9.4. Biopharmaceuticals
    • 9.4.1. Biopharmaceuticals Market, 2018 - 2030 (USD Million)
  • 9.5. Speciality Industrial Chemicals
    • 9.5.1. Speciality Industrial Chemicals Market, 2018 - 2030 (USD Million)
  • 9.6. In-House
    • 9.6.1. In-House Market, 2018 - 2030 (USD Million)
  • 9.7. Outsourced
    • 9.7.1. Outsourced Market, 2018 - 2030 (USD Million)

Chapter 10. Large and Small-Scale Bioprocessing Market: Regional Estimates & Trend Analysis

  • 10.1. Regional Market Share Analysis, 2024 & 2030
  • 10.2. Regional Market Dashboard
  • 10.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 10.4. North America
    • 10.4.1. North America Large and Small-Scale Bioprocessing Market Estimates and Forecasts, By Country, 2018 - 2030 (USD Million)
    • 10.4.2. U.S.
      • 10.4.2.1. Key Country Dynamics
      • 10.4.2.2. Regulatory Framework
      • 10.4.2.3. Competitive Insights
      • 10.4.2.4. U.S. Large and Small-Scale Bioprocessing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 10.4.3. Canada
      • 10.4.3.1. Key Country Dynamics
      • 10.4.3.2. Regulatory Framework
      • 10.4.3.3. Competitive Insights
      • 10.4.3.4. Canada Large and Small-Scale Bioprocessing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 10.4.4. Mexico
      • 10.4.4.1. Key Country Dynamics
      • 10.4.4.2. Regulatory Framework
      • 10.4.4.3. Competitive Insights
      • 10.4.4.4. Mexico Large and Small-Scale Bioprocessing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 10.5. Europe
    • 10.5.1. Europe Large and Small-Scale Bioprocessing Market Estimates and Forecasts, By Country, 2018 - 2030 (USD Million)
    • 10.5.2. Germany
      • 10.5.2.1. Key Country Dynamics
      • 10.5.2.2. Regulatory Framework
      • 10.5.2.3. Competitive Insights
      • 10.5.2.4. Germany Large and Small-Scale Bioprocessing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 10.5.3. UK
      • 10.5.3.1. Key Country Dynamics
      • 10.5.3.2. Regulatory Framework
      • 10.5.3.3. Competitive Insights
      • 10.5.3.4. UK Large and Small-Scale Bioprocessing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 10.5.4. France
      • 10.5.4.1. Key Country Dynamics
      • 10.5.4.2. Regulatory Framework
      • 10.5.4.3. Competitive Insights
      • 10.5.4.4. France Large and Small-Scale Bioprocessing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 10.5.5. Italy
      • 10.5.5.1. Key Country Dynamics
      • 10.5.5.2. Regulatory Framework
      • 10.5.5.3. Competitive Insights
      • 10.5.5.4. Italy Large and Small-Scale Bioprocessing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 10.5.6. Spain
      • 10.5.6.1. Key Country Dynamics
      • 10.5.6.2. Regulatory Framework
      • 10.5.6.3. Competitive Insights
      • 10.5.6.4. Spain Large and Small-Scale Bioprocessing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 10.5.7. Denmark
      • 10.5.7.1. Key Country Dynamics
      • 10.5.7.2. Regulatory Framework
      • 10.5.7.3. Competitive Insights
      • 10.5.7.4. Denmark Large and Small-Scale Bioprocessing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 10.5.8. Sweden
      • 10.5.8.1. Key Country Dynamics
      • 10.5.8.2. Regulatory Framework
      • 10.5.8.3. Competitive Insights
      • 10.5.8.4. Sweden Large and Small-Scale Bioprocessing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 10.5.9. Norway
      • 10.5.9.1. Key Country Dynamics
      • 10.5.9.2. Regulatory Framework
      • 10.5.9.3. Competitive Insights
      • 10.5.9.4. Norway Large and Small-Scale Bioprocessing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 10.6. Asia Pacific
    • 10.6.1. Asia Pacific Large and Small-Scale Bioprocessing Market Estimates and Forecasts, By Country, 2018 - 2030 (USD Million)
    • 10.6.2. Japan
      • 10.6.2.1. Key Country Dynamics
      • 10.6.2.2. Regulatory Framework
      • 10.6.2.3. Competitive Insights
      • 10.6.2.4. Japan Large and Small-Scale Bioprocessing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 10.6.3. China
      • 10.6.3.1. Key Country Dynamics
      • 10.6.3.2. Regulatory Framework
      • 10.6.3.3. Competitive Insights
      • 10.6.3.4. China Large and Small-Scale Bioprocessing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 10.6.4. India
      • 10.6.4.1. Key Country Dynamics
      • 10.6.4.2. Regulatory Framework
      • 10.6.4.3. Competitive Insights
      • 10.6.4.4. India Large and Small-Scale Bioprocessing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 10.6.5. Australia
      • 10.6.5.1. Key Country Dynamics
      • 10.6.5.2. Regulatory Framework
      • 10.6.5.3. Competitive Insights
      • 10.6.5.4. Australia Large and Small-Scale Bioprocessing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 10.6.6. Thailand
      • 10.6.6.1. Key Country Dynamics
      • 10.6.6.2. Regulatory Framework
      • 10.6.6.3. Competitive Insights
      • 10.6.6.4. Thailand Large and Small-Scale Bioprocessing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 10.6.7. South Korea
      • 10.6.7.1. Key Country Dynamics
      • 10.6.7.2. Regulatory Framework
      • 10.6.7.3. Competitive Insights
      • 10.6.7.4. South Korea Large and Small-Scale Bioprocessing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 10.7. Latin America
    • 10.7.1. Latin America Large and Small-Scale Bioprocessing Market Estimates and Forecasts, By Country, 2018 - 2030 (USD Million)
    • 10.7.2. Brazil
      • 10.7.2.1. Key Country Dynamics
      • 10.7.2.2. Regulatory Framework
      • 10.7.2.3. Competitive Insights
      • 10.7.2.4. Brazil Large and Small-Scale Bioprocessing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 10.7.3. Argentina
      • 10.7.3.1. Key Country Dynamics
      • 10.7.3.2. Regulatory Framework
      • 10.7.3.3. Competitive Insights
      • 10.7.3.4. Argentina Large and Small-Scale Bioprocessing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 10.8. MEA
    • 10.8.1. MEA Large and Small-Scale Bioprocessing Market Estimates and Forecasts, By Country, 2018 - 2030 (USD Million)
    • 10.8.2. South Africa
      • 10.8.2.1. Key Country Dynamics
      • 10.8.2.2. Regulatory Framework
      • 10.8.2.3. Competitive Insights
      • 10.8.2.4. South Africa Large and Small-Scale Bioprocessing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 10.8.3. Saudi Arabia
      • 10.8.3.1. Key Country Dynamics
      • 10.8.3.2. Regulatory Framework
      • 10.8.3.3. Competitive Insights
      • 10.8.3.4. Saudi Arabia Large and Small-Scale Bioprocessing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 10.8.4. UAE
      • 10.8.4.1. Key Country Dynamics
      • 10.8.4.2. Regulatory Framework
      • 10.8.4.3. Competitive Insights
      • 10.8.4.4. UAE Large and Small-Scale Bioprocessing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 10.8.5. Kuwait
      • 10.8.5.1. Key Country Dynamics
      • 10.8.5.2. Regulatory Framework
      • 10.8.5.3. Competitive Insights
      • 10.8.5.4. Kuwait Large and Small-Scale Bioprocessing Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 11. Competitive Landscape

  • 11.1. Participant Overview
  • 11.2. Company Market Position Analysis
  • 11.3. Company Categorization
  • 11.4. Strategy Mapping
  • 11.5. Company Profiles/Listing
    • 11.5.1. Merck KGaA
      • 11.5.1.1. Overview
      • 11.5.1.2. Financial Performance
      • 11.5.1.3. Product Benchmarking
      • 11.5.1.4. Strategic Initiatives
    • 11.5.2. Thermo Fisher Scientific, Inc.
      • 11.5.2.1. Overview
      • 11.5.2.2. Financial Performance
      • 11.5.2.3. Product Benchmarking
      • 11.5.2.4. Strategic Initiatives
    • 11.5.3. GE healthcare
      • 11.5.3.1. Overview
      • 11.5.3.2. Financial Performance
      • 11.5.3.3. Product Benchmarking
      • 11.5.3.4. Strategic Initiatives
    • 11.5.4. Corning, Inc.
      • 11.5.4.1. Overview
      • 11.5.4.2. Financial Performance
      • 11.5.4.3. Product Benchmarking
      • 11.5.4.4. Strategic Initiatives
    • 11.5.5. Sartorius AG
      • 11.5.5.1. Overview
      • 11.5.5.2. Financial Performance
      • 11.5.5.3. Product Benchmarking
      • 11.5.5.4. Strategic Initiatives
    • 11.5.6. CESCO BIOENGINEERING CO., LTD
      • 11.5.6.1. Overview
      • 11.5.6.2. Financial Performance
      • 11.5.6.3. Product Benchmarking
      • 11.5.6.4. Strategic Initiatives
    • 11.5.7. Bio-Process Group
      • 11.5.7.1. Overview
      • 11.5.7.2. Financial Performance
      • 11.5.7.3. Product Benchmarking
      • 11.5.7.4. Strategic Initiatives
    • 11.5.8. Bioprocess Control AB
      • 11.5.8.1. Overview
      • 11.5.8.2. Financial Performance
      • 11.5.8.3. Product Benchmarking
      • 11.5.8.4. Strategic Initiatives
    • 11.5.9. Eppendorf AG
      • 11.5.9.1. Overview
      • 11.5.9.2. Financial Performance
      • 11.5.9.3. Product Benchmarking
      • 11.5.9.4. Strategic Initiatives
    • 11.5.10. Applikon Biotechnology
      • 11.5.10.1. Overview
      • 11.5.10.2. Financial Performance
      • 11.5.10.3. Product Benchmarking
      • 11.5.10.4. Strategic Initiatives
    • 11.5.11. Lonza
      • 11.5.11.1. Overview
      • 11.5.11.2. Financial Performance
      • 11.5.11.3. Product Benchmarking
      • 11.5.11.4. Strategic Initiatives
    • 11.5.12. PBS Biotech, Inc
      • 11.5.12.1. Overview
      • 11.5.12.2. Financial Performance
      • 11.5.12.3. Product Benchmarking
      • 11.5.12.4. Strategic Initiatives
    • 11.5.13. Finesse
      • 11.5.13.1. Overview
      • 11.5.13.2. Financial Performance
      • 11.5.13.3. Product Benchmarking
      • 11.5.13.4. Strategic Initiatives
    • 11.5.14. Meissner Filtration Products, Inc.
      • 11.5.14.1. Overview
      • 11.5.14.2. Financial Performance
      • 11.5.14.3. Product Benchmarking
      • 11.5.14.4. Strategic Initiatives
    • 11.5.15. CellGenix GmbH
      • 11.5.15.1. Overview
      • 11.5.15.2. Financial Performance
      • 11.5.15.3. Product Benchmarking
      • 11.5.15.4. Strategic Initiatives
    • 11.5.16. Boehringer Ingelheim
      • 11.5.16.1. Overview
      • 11.5.16.2. Financial Performance
      • 11.5.16.3. Product Benchmarking
      • 11.5.16.4. Strategic Initiatives
    • 11.5.17. Samsung BioLogics
      • 11.5.17.1. Overview
      • 11.5.17.2. Financial Performance
      • 11.5.17.3. Product Benchmarking
      • 11.5.17.4. Strategic Initiatives
    • 11.5.18. Patheon
      • 11.5.18.1. Overview
      • 11.5.18.2. Financial Performance
      • 11.5.18.3. Product Benchmarking
      • 11.5.18.4. Strategic Initiatives
    • 11.5.19. CMC Biologics
      • 11.5.19.1. Overview
      • 11.5.19.2. Financial Performance
      • 11.5.19.3. Product Benchmarking
      • 11.5.19.4. Strategic Initiatives
    • 11.5.20. Binex Co., Ltd
      • 11.5.20.1. Overview
      • 11.5.20.2. Financial Performance
      • 11.5.20.3. Product Benchmarking
      • 11.5.20.4. Strategic Initiatives
    • 11.5.21. Rentschler Biotechnology GmbH
      • 11.5.21.1. Overview
      • 11.5.21.2. Financial Performance
      • 11.5.21.3. Product Benchmarking
      • 11.5.21.4. Strategic Initiatives
    • 11.5.22. TOYOBA CO., LTD.
      • 11.5.22.1. Overview
      • 11.5.22.2. Financial Performance
      • 11.5.22.3. Product Benchmarking
      • 11.5.22.4. Strategic Initiatives
    • 11.5.23. Inno Biologics Sdn Bhd
      • 11.5.23.1. Overview
      • 11.5.23.2. Financial Performance
      • 11.5.23.3. Product Benchmarking
      • 11.5.23.4. Strategic Initiatives
    • 11.5.24. F. Hoffmann-La Roche Ltd
      • 11.5.24.1. Overview
      • 11.5.24.2. Financial Performance
      • 11.5.24.3. Product Benchmarking
      • 11.5.24.4. Strategic Initiatives
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제